Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George¿s Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months
Status: Enrolling
Updated:  6/7/2017
205.440.1011 Boehringer Ingelheim Investigational Site
mi
from
Lebanon, NH
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George¿s Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months
Status: Enrolling
Updated: 6/7/2017
205.440.1011 Boehringer Ingelheim Investigational Site
mi
from
Lebanon, NH
Click here to add this to my saved trials
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George¿s Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months
Status: Enrolling
Updated:  6/7/2017
1160.129.32038 Boehringer Ingelheim Investigational Site
mi
from
Mineola, NY
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George¿s Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months
Status: Enrolling
Updated: 6/7/2017
1160.129.32038 Boehringer Ingelheim Investigational Site
mi
from
Mineola, NY
Click here to add this to my saved trials
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George¿s Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months
Status: Enrolling
Updated:  6/7/2017
205.452.01287 Boehringer Ingelheim Investigational Site
mi
from
Toledo, OH
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George¿s Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months
Status: Enrolling
Updated: 6/7/2017
205.452.01287 Boehringer Ingelheim Investigational Site
mi
from
Toledo, OH
Click here to add this to my saved trials
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George¿s Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months
Status: Enrolling
Updated:  6/7/2017
Boehringer Ingelheim Investigational Site
mi
from
Portland, OR
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George¿s Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months
Status: Enrolling
Updated: 6/7/2017
Boehringer Ingelheim Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George¿s Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months
Status: Enrolling
Updated:  6/7/2017
Boehringer Ingelheim Investigational Site
mi
from
Charleston, SC
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George¿s Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months
Status: Enrolling
Updated: 6/7/2017
Boehringer Ingelheim Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George¿s Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months
Status: Enrolling
Updated:  6/7/2017
1200.71.1002 Boehringer Ingelheim Investigational Site
mi
from
Nashville, TN
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George¿s Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months
Status: Enrolling
Updated: 6/7/2017
1200.71.1002 Boehringer Ingelheim Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George¿s Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months
Status: Enrolling
Updated:  6/7/2017
Boehringer Ingelheim Investigational Site
mi
from
Dallas, TX
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George¿s Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months
Status: Enrolling
Updated: 6/7/2017
Boehringer Ingelheim Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George¿s Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months
Status: Enrolling
Updated:  6/7/2017
1218.89.11004 Boehringer Ingelheim Investigational Site
mi
from
Edmonton,
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George¿s Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months
Status: Enrolling
Updated: 6/7/2017
1218.89.11004 Boehringer Ingelheim Investigational Site
mi
from
Edmonton,
Click here to add this to my saved trials
Dexamethasone Dyspnea Study
A Preliminary Study of Dexamethasone for Dyspnea in Cancer Patients
Status: Enrolling
Updated:  6/19/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Dexamethasone Dyspnea Study
A Preliminary Study of Dexamethasone for Dyspnea in Cancer Patients
Status: Enrolling
Updated: 6/19/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Sustained Effects of Hypertonic Saline on Mucociliary Clearance in Subjects With Chronic Bronchitis
Novel Therapies for Muco-Obstructive Lung Diseases: Sustained Effects of Hypertonic Saline on Mucociliary Clearance and Clinical Tolerability in Subjects With Chronic Bronchitis
Status: Enrolling
Updated:  6/22/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Sustained Effects of Hypertonic Saline on Mucociliary Clearance in Subjects With Chronic Bronchitis
Novel Therapies for Muco-Obstructive Lung Diseases: Sustained Effects of Hypertonic Saline on Mucociliary Clearance and Clinical Tolerability in Subjects With Chronic Bronchitis
Status: Enrolling
Updated: 6/22/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects
Novel Therapies for Muco-Obstructive Lung Diseases: A Study of Tolerability and MCC Effect of Hypertonic Saline Delivered Via the tPAD in Patients With Chronic Bronchitis
Status: Enrolling
Updated:  6/22/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects
Novel Therapies for Muco-Obstructive Lung Diseases: A Study of Tolerability and MCC Effect of Hypertonic Saline Delivered Via the tPAD in Patients With Chronic Bronchitis
Status: Enrolling
Updated: 6/22/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Effect of Feedings on Caffeine in Premature Infants
Effect of Feedings on Caffeine Pharmacokinetics and Metabolism in Premature Infants
Status: Enrolling
Updated:  6/27/2017
North Carolina Children's Hospital
mi
from
Chapel Hill, NC
Effect of Feedings on Caffeine in Premature Infants
Effect of Feedings on Caffeine Pharmacokinetics and Metabolism in Premature Infants
Status: Enrolling
Updated: 6/27/2017
North Carolina Children's Hospital
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Effect of Feedings on Caffeine in Premature Infants
Effect of Feedings on Caffeine Pharmacokinetics and Metabolism in Premature Infants
Status: Enrolling
Updated:  6/27/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Effect of Feedings on Caffeine in Premature Infants
Effect of Feedings on Caffeine Pharmacokinetics and Metabolism in Premature Infants
Status: Enrolling
Updated: 6/27/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Pennsylvania Study Of Chronic Obstructive Pulmonary Exacerbations
Pennsylvania Study of Chronic Obstructive Pulmonary Exacerbations (PA-SCOPE)
Status: Enrolling
Updated:  6/28/2017
Lancaster General Hospital
mi
from
Lancaster, PA
Pennsylvania Study Of Chronic Obstructive Pulmonary Exacerbations
Pennsylvania Study of Chronic Obstructive Pulmonary Exacerbations (PA-SCOPE)
Status: Enrolling
Updated: 6/28/2017
Lancaster General Hospital
mi
from
Lancaster, PA
Click here to add this to my saved trials
Pennsylvania Study Of Chronic Obstructive Pulmonary Exacerbations
Pennsylvania Study of Chronic Obstructive Pulmonary Exacerbations (PA-SCOPE)
Status: Enrolling
Updated:  6/28/2017
Western Pennsylvania Hospital
mi
from
Pittsburgh, PA
Pennsylvania Study Of Chronic Obstructive Pulmonary Exacerbations
Pennsylvania Study of Chronic Obstructive Pulmonary Exacerbations (PA-SCOPE)
Status: Enrolling
Updated: 6/28/2017
Western Pennsylvania Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pennsylvania Study Of Chronic Obstructive Pulmonary Exacerbations
Pennsylvania Study of Chronic Obstructive Pulmonary Exacerbations (PA-SCOPE)
Status: Enrolling
Updated:  6/28/2017
Temple University School of Medicine
mi
from
Philadelphia, PA
Pennsylvania Study Of Chronic Obstructive Pulmonary Exacerbations
Pennsylvania Study of Chronic Obstructive Pulmonary Exacerbations (PA-SCOPE)
Status: Enrolling
Updated: 6/28/2017
Temple University School of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Peer-Driven Intervention for Sleep Apnea
Peer-Driven Intervention as an Alternate Model of Care Delivery and Coordination for Sleep Apnea
Status: Enrolling
Updated:  6/30/2017
University of Arizona Center for Sleep Disorders
mi
from
Tucson, AZ
Peer-Driven Intervention for Sleep Apnea
Peer-Driven Intervention as an Alternate Model of Care Delivery and Coordination for Sleep Apnea
Status: Enrolling
Updated: 6/30/2017
University of Arizona Center for Sleep Disorders
mi
from
Tucson, AZ
Click here to add this to my saved trials
Myocardial Ischemia Detection for Early Identification of Patients With Ischemic Chest Pain
Myocardial Ischemia Detection for Early Identification of Patients With Ischemic Chest Pain
Status: Enrolling
Updated:  7/10/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Myocardial Ischemia Detection for Early Identification of Patients With Ischemic Chest Pain
Myocardial Ischemia Detection for Early Identification of Patients With Ischemic Chest Pain
Status: Enrolling
Updated: 7/10/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated:  7/18/2017
Novartis
mi
from
Denver, CO
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated: 7/18/2017
Novartis
mi
from
Denver, CO
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated:  7/18/2017
Novartis Investigative Site
mi
from
Brussel,
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated: 7/18/2017
Novartis Investigative Site
mi
from
Brussel,
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated:  7/18/2017
Novartis Investigator Site
mi
from
Birmingham, AL
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated: 7/18/2017
Novartis Investigator Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated:  7/18/2017
Novartis Investigator Site
mi
from
Chicago, IL
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated: 7/18/2017
Novartis Investigator Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated:  7/18/2017
Novartis Investigative Site
mi
from
Louisville, KY
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated: 7/18/2017
Novartis Investigative Site
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated:  7/18/2017
Novartis Investigative site
mi
from
Boston, MA
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated: 7/18/2017
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated:  7/18/2017
Novartis Investigative Site
mi
from
Saint Louis, MO
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated: 7/18/2017
Novartis Investigative Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated:  7/18/2017
Novartis Investigative Site
mi
from
Chapel Hill, NC
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated: 7/18/2017
Novartis Investigative Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated:  7/18/2017
Novartis Investigative Site
mi
from
Columbus, OH
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients
Status: Enrolling
Updated: 7/18/2017
Novartis Investigative Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Retrospective Review of Mechanically Ventilated Patients Using a Continuous Data Collection System.
Retrospective Review of Mechanically Ventilated Patients
Status: Enrolling
Updated:  7/18/2017
Boston Children's Hospital
mi
from
Boston, MA
Retrospective Review of Mechanically Ventilated Patients Using a Continuous Data Collection System.
Retrospective Review of Mechanically Ventilated Patients
Status: Enrolling
Updated: 7/18/2017
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Imaging Airway Liquid Absorption in Cystic Fibrosis
Imaging Airway Liquid Absorption in Cystic Fibrosis
Status: Enrolling
Updated:  7/24/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Imaging Airway Liquid Absorption in Cystic Fibrosis
Imaging Airway Liquid Absorption in Cystic Fibrosis
Status: Enrolling
Updated: 7/24/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of Lung Clearance After Hypertonic Saline Delivery Using the tPAD Device
A Randomized Crossover Mucociliary Clearance Study of Aerosolized 7% NaCl Solution Administered Overnight by the tPAD Device to Subjects With Cystic Fibrosis
Status: Enrolling
Updated:  7/24/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
A Study of Lung Clearance After Hypertonic Saline Delivery Using the tPAD Device
A Randomized Crossover Mucociliary Clearance Study of Aerosolized 7% NaCl Solution Administered Overnight by the tPAD Device to Subjects With Cystic Fibrosis
Status: Enrolling
Updated: 7/24/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Assessing Mucociliary Clearance and Airway Liquid Volume in the CF Airway
Pilot Study of a New Technique for Assessing Mucociliary Clearance and Airway Surface Liquid Volume in Cystic Fibrosis
Status: Enrolling
Updated:  7/24/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Assessing Mucociliary Clearance and Airway Liquid Volume in the CF Airway
Pilot Study of a New Technique for Assessing Mucociliary Clearance and Airway Surface Liquid Volume in Cystic Fibrosis
Status: Enrolling
Updated: 7/24/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Sleep and Circadian Rhythms in Mechanically Ventilated Patients
Sleep and Circadian Rhythms in Mechanically Ventilated Patients: a Feasibility and Mechanistic Study.
Status: Enrolling
Updated:  7/25/2017
University of Chicago
mi
from
Chicago, IL
Sleep and Circadian Rhythms in Mechanically Ventilated Patients
Sleep and Circadian Rhythms in Mechanically Ventilated Patients: a Feasibility and Mechanistic Study.
Status: Enrolling
Updated: 7/25/2017
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis
Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  7/25/2017
University of Michigan Medical Center
mi
from
Ann Arbor, MI
Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis
Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 7/25/2017
University of Michigan Medical Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
A Study to Determine PK Profiles of AUGMENTIN XR in Adolescents Weight at Least 40 kg Receiving Augmentin XR BID for 10 Days
Status: Enrolling
Updated:  7/31/2017
GSK Investigational Site
mi
from
Little Rock, AR
Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
A Study to Determine PK Profiles of AUGMENTIN XR in Adolescents Weight at Least 40 kg Receiving Augmentin XR BID for 10 Days
Status: Enrolling
Updated: 7/31/2017
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
A Study to Determine PK Profiles of AUGMENTIN XR in Adolescents Weight at Least 40 kg Receiving Augmentin XR BID for 10 Days
Status: Enrolling
Updated:  7/31/2017
GSK Investigational Site
mi
from
Huntington Beach, CA
Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
A Study to Determine PK Profiles of AUGMENTIN XR in Adolescents Weight at Least 40 kg Receiving Augmentin XR BID for 10 Days
Status: Enrolling
Updated: 7/31/2017
GSK Investigational Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
A Study to Determine PK Profiles of AUGMENTIN XR in Adolescents Weight at Least 40 kg Receiving Augmentin XR BID for 10 Days
Status: Enrolling
Updated:  7/31/2017
GSK Investigational Site
mi
from
North Dartmouth, MA
Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
A Study to Determine PK Profiles of AUGMENTIN XR in Adolescents Weight at Least 40 kg Receiving Augmentin XR BID for 10 Days
Status: Enrolling
Updated: 7/31/2017
GSK Investigational Site
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
A Study to Determine PK Profiles of AUGMENTIN XR in Adolescents Weight at Least 40 kg Receiving Augmentin XR BID for 10 Days
Status: Enrolling
Updated:  7/31/2017
GSK Investigational Site
mi
from
Sylva, NC
Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
A Study to Determine PK Profiles of AUGMENTIN XR in Adolescents Weight at Least 40 kg Receiving Augmentin XR BID for 10 Days
Status: Enrolling
Updated: 7/31/2017
GSK Investigational Site
mi
from
Sylva, NC
Click here to add this to my saved trials
Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
A Study to Determine PK Profiles of AUGMENTIN XR in Adolescents Weight at Least 40 kg Receiving Augmentin XR BID for 10 Days
Status: Enrolling
Updated:  7/31/2017
GSK Investigational Site
mi
from
Cleveland, OH
Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
A Study to Determine PK Profiles of AUGMENTIN XR in Adolescents Weight at Least 40 kg Receiving Augmentin XR BID for 10 Days
Status: Enrolling
Updated: 7/31/2017
GSK Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
A Study to Determine PK Profiles of AUGMENTIN XR in Adolescents Weight at Least 40 kg Receiving Augmentin XR BID for 10 Days
Status: Enrolling
Updated:  7/31/2017
GSK Investigational Site
mi
from
Erie, PA
Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
A Study to Determine PK Profiles of AUGMENTIN XR in Adolescents Weight at Least 40 kg Receiving Augmentin XR BID for 10 Days
Status: Enrolling
Updated: 7/31/2017
GSK Investigational Site
mi
from
Erie, PA
Click here to add this to my saved trials
Brain Imaging: Cocaine Effects & Medication Development - 5
Brain Imaging: Cocaine Effects & Medication Development
Status: Enrolling
Updated:  8/1/2017
New York State Psychiatric Institute
mi
from
New York, NY
Brain Imaging: Cocaine Effects & Medication Development - 5
Brain Imaging: Cocaine Effects & Medication Development
Status: Enrolling
Updated: 8/1/2017
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Pilot Study of the MultiSense Patch to Record Cardiopulmonary Data During Sleep and Wake Cycles
Pilot Study of the MultiSense Patch to Record Cardiopulmonary Data During Sleep and Wake Cycles
Status: Enrolling
Updated:  8/3/2017
Scripps Translational Science Institute
mi
from
La Jolla, CA
Pilot Study of the MultiSense Patch to Record Cardiopulmonary Data During Sleep and Wake Cycles
Pilot Study of the MultiSense Patch to Record Cardiopulmonary Data During Sleep and Wake Cycles
Status: Enrolling
Updated: 8/3/2017
Scripps Translational Science Institute
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese Men
A Phase I, Randomized, Single-blind, Placebo-controlled, Sequential-group, Single-center Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of AZD7594 Given Once Daily as Inhaled Formulation in Healthy Japanese Men
Status: Enrolling
Updated:  8/4/2017
Clinical Research Facility
mi
from
Glendale, CA
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese Men
A Phase I, Randomized, Single-blind, Placebo-controlled, Sequential-group, Single-center Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of AZD7594 Given Once Daily as Inhaled Formulation in Healthy Japanese Men
Status: Enrolling
Updated: 8/4/2017
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Comparative Effectiveness of Antibiotics for Respiratory Infections
Comparative Effectiveness of Broad vs. Narrow Spectrum Antibiotics for Acute Respiratory Tract Infections in Children
Status: Enrolling
Updated:  8/11/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Comparative Effectiveness of Antibiotics for Respiratory Infections
Comparative Effectiveness of Broad vs. Narrow Spectrum Antibiotics for Acute Respiratory Tract Infections in Children
Status: Enrolling
Updated: 8/11/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube
Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube After Intubation of Critically Ill Patients
Status: Enrolling
Updated:  8/23/2017
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube
Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube After Intubation of Critically Ill Patients
Status: Enrolling
Updated: 8/23/2017
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube
Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube After Intubation of Critically Ill Patients
Status: Enrolling
Updated:  8/23/2017
VA Loma Linda Healthcare System
mi
from
Loma Linda, CA
Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube
Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube After Intubation of Critically Ill Patients
Status: Enrolling
Updated: 8/23/2017
VA Loma Linda Healthcare System
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube
Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube After Intubation of Critically Ill Patients
Status: Enrolling
Updated:  8/23/2017
Riverside University Medical Center
mi
from
Moreno Valley, CA
Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube
Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube After Intubation of Critically Ill Patients
Status: Enrolling
Updated: 8/23/2017
Riverside University Medical Center
mi
from
Moreno Valley, CA
Click here to add this to my saved trials
An Intervention to Improve Function in Severe Cardiopulmonary Illness
An Intervention to Enhance Function in Severe Cardiopulmonary Illness
Status: Enrolling
Updated:  8/30/2017
VA Puget Sound Health Care System
mi
from
Seattle, WA
An Intervention to Improve Function in Severe Cardiopulmonary Illness
An Intervention to Enhance Function in Severe Cardiopulmonary Illness
Status: Enrolling
Updated: 8/30/2017
VA Puget Sound Health Care System
mi
from
Seattle, WA
Click here to add this to my saved trials
Effect of Macrolide Antibiotics on Airway Inflammation in People With Chronic Obstructive Pulmonary Disease (COPD)
Effect of Macrolide Treatment on a Novel Pathway of Neutrophilic Inflammation in COPD
Status: Enrolling
Updated:  8/31/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Effect of Macrolide Antibiotics on Airway Inflammation in People With Chronic Obstructive Pulmonary Disease (COPD)
Effect of Macrolide Treatment on a Novel Pathway of Neutrophilic Inflammation in COPD
Status: Enrolling
Updated: 8/31/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Soluble Tumor Necrosis Factor Receptor: Enbrel® (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated:  9/1/2017
New York Medical College
mi
from
Valhalla, NY
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Soluble Tumor Necrosis Factor Receptor: Enbrel® (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated: 9/1/2017
New York Medical College
mi
from
Valhalla, NY
Click here to add this to my saved trials
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Soluble Tumor Necrosis Factor Receptor: Enbrel® (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated:  9/1/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Soluble Tumor Necrosis Factor Receptor: Enbrel® (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated: 9/1/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials